Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
 
Email
gmslwtd@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2010 TO 2020]

Results 1-20 of 26 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
12018A merged lung cancer transcriptome dataset for clinical predictive modelingLim, S.B; Tan, S.J; Lim, W.-T ; Lim, C.T 
2Sep-2012A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerBible, K.C.; Suman, V.J.; Menefee, M.E.; Smallridge, R.C.; Molina, J.R.; Maples, W.J.; Karlin, N.J.; Traynor, A.M.; Kumar, P.; Goh, B.C.; Lim, W.-T. ; Bossou, A.R.; Isham, C.R.; Webster, K.P.; Kukla, A.K.; Bieber, C.; Burton, J.K.; Harris, P.; Erlichman, C.
315-Aug-2011A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinomaLim, W.-T. ; Ng, Q.-S.; Ivy, P.; Leong, S.-S.; Singh, O.; Chowbay, B.; Gao, F.; Thng, C.H.; Goh, B.-C. ; Tan, D.S.-W.; Koh, T.S.; Toh, C.-K.; Tan, E.-H. 
42017A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSoh, S.X; Siddiqui, F.J ; Allen, J.C ; Kim, G.W; Lee, J.C; Yatabe, Y; Soda, M; Mano, H; Soo, R.A ; Chin, T.-M ; Ebi, H; Yano, S; Matsuo, K; Niu, X; Lu, S; Isobe, K; Lee, J.-H; Yang, J.C; Zhao, M; Zhou, C; Lee, J.-K; Lee, S.-H; Lee, J.Y; Ahn, M.-J; Tan, T.J; Tan, D.S ; Tan, E.-H; Ong, S.T ; Lim, W.-T 
53-Sep-2019Addressing cellular heterogeneity in tumor and circulation for refined prognosticationLim, Su Bin; Yeo, Trifanny ; Lee, Wen Di ; Bhagat, Ali Asgar S ; Tan, Swee Jin; Tan, Daniel Shao Weng ; Lim, Wan-Teck ; Lim, Chwee Teck 
62017An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancerLim, S.B; Tan, S.J; Lim, W.-T ; Lim, C.T 
72019Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).Fong, Pei Yuan; Tan, Sze Huey ; Lim, Darren Wan Teck ; Tan, Eng Huat ; Ng, Quan Sing ; Sommat, Kiattisa ; Tan, Daniel Shao Weng ; Ang, Mei Kim 
82014Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancerTan, D.S.W; Haaland, B ; Gan, J.M; Tham, S.C; Sinha, I; Tan, E.H; Lim, K.H ; Takano, A ; Krisna, S.S; Thu, M.M.M; Liew, H.P; Ullrich, A; Lim, W.-T ; Chua, B.T
98-Oct-2019Compendiums of cancer transcriptomes for machine learning applicationsLim, Su Bin; Tan, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
102018Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspectiveTan, P.-T; Aziz, M.I.A; Pearce, F; Lim, W.-T ; Wu, D.B.-C; Ng, K
112018Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencingNahar, R; Zhai, W; Zhang, T; Takano, A; Khng, A.J; Lee, Y.Y; Liu, X; Lim, C.H; Koh, T.P.T; Aung, Z.W; Lim, T.K.H ; Veeravalli, L; Yuan, J; Teo, A.S.M; Chan, C.X; Poh, H.M; Chua, I.M.L; Liew, A.A; Lau, D.P.X; Kwang, X.L; Toh, C.K; Lim, W.-T ; Lim, B; Tam, W.L ; Tan, E.-H ; Hillmer, A.M; Tan, D.S.W
121-Jan-2020First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology DrugTeneggi, V; Novotny-Diermayr, V; Lee, LH; Yasin, M; Yeo, P; Ethirajulu, K; Gan, SBH; Blanchard, SE; Nellore, R; Umrani, DN; Gomeni, R; Teck, DLW ; Li, G; Lu, QS; Cao, Y; Matter, A 
131-Apr-2019First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical settingPark, Keunchil; Lim, Darren Wan-Teck ; Okamoto, Isamu; Yang, James Chih-Hsin
142015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. 
153-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
1624-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
172-Oct-2019Liquid biopsy: one cell at a timeLim, Su Bin; Lee, Wen Di ; Vasudevan, Jyothsna; Lim, Wan-Teck ; Lim, Chwee Teck 
1829-Feb-2016Microfluidic enrichment for the single cell analysis of circulating tumor cellsYeo, Trifanny ; Tan, Swee Jin; Lim, Chew Leng; Lau, Dawn Ping Xi; Chua, Yong Wei; Krisna, Sai Sakktee; Iyer, Gopal ; Tan, Gek San ; Lim, Tony Kiat Hon; Tan, Daniel SW ; Lim, Wan-Teck ; Lim, Chwee Teck 
1922-May-2019Pan-cancer analysis connects tumor matrisome to immune responseLim, Su Bin; Chua, Melvin Lee Kiang ; Yeong, Joe Poh Sheng; Jin, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
2030-Dec-2019Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsBang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck ; Bauer, Todd M; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette